Bolt Biotherapeutics BOLT

Quarterly report 2026-Q1
added 05-12-2026

Country	USA
IPO year	2021
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	1.87 M
Market Cap^[1]	$ 7.59 M
EBITDA (LTM)	$ -35.4 M
P/E (LTM)	-0.37
P/S (LTM)	34.62
EPS (LTM)	-12.78

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.